Entrada Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $495k | 39k | 12.62 |
| 2024-12-31 | $618k | 36k | 17.29 |
| 2024-09-30 | $544k | 34k | 15.98 |
| 2024-06-30 | $412k | 29k | 14.25 |
| 2024-03-31 | $320k | 23k | 14.17 |
| 2023-12-31 | $414k | 27k | 15.09 |
| 2023-09-30 | $369k | 23k | 15.80 |
| 2023-06-30 | $330k | 22k | 15.14 |
| 2023-03-31 | $490k | 34k | 14.50 |
| 2022-12-31 | $72k | 5.3k | 13.52 |
| 2022-06-30 | $158k | 13k | 12.16 |
| 2021-12-31 | $391k | 23k | 17.12 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation